EVAX today
$2.80-$0.11 (-3.70%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourBearish
15 minStrong Bearish
5 minConsolidating
Daily trend turns up above $3.64
Key levels
Resistance$3.64
Resistance$3.19
Support$2.72
Support$2.26
Latest news & SEC filings
DealEvaxion Updates SEC Filing Tied to European Investment Bank Debt Deal
NewsEvaxion A/S amends SEC registration filing tied to European Investment Bank arrangement
ProductEvaxion Releases Phase 2 Results for Cancer Vaccine EVX-01
All EVAX news →About Evaxion
Evaxion is a clinical-stage biotechnology company that uses artificial intelligence to discover and develop vaccines and immunotherapies. Its pipeline targets infectious diseases and cancer, with candidates advanced through preclinical and early clinical testing. The company operates in Denmark and the United States, and pursues partnerships with larger pharmaceutical firms to develop and commercialize its product candidates.
Based on the company's 20-F filed Mar 5, 2026.
Nasdaq · Healthcare
Evaxion A/S (EVAX)
What Is the Price Target for EVAX?
SEPT Low Target
$13.60
SEPT Mid Target
$16.00
SEPT High Target
$18.40
Analyst Consensus
$16.00
Is EVAX a Buy or Sell Right Now?
Thesis
- •Revenue growing 125.8% YoY with STRONG trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EVAX.
Start Free Trial →Is EVAX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$11.40
38
Moat Score
NONE
4/9
Piotroski Score
-5.2
Altman Z-Score
What Is Smart Money Doing with EVAX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →EVAX Growth Story
Revenue YoY
125.8%
3yr Revenue CAGR
N/A%
EPS Growth YoY
87.65%
FCF Growth YoY
48.6%
Revenue Trend
STRONG
Dark Pool Trades for EVAX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for EVAX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:32:11 | $2.78 | 1,500 | $$4K | SELL |
| 15:44:08 | $2.87 | 2,800 | $$8K | BUY |
| 15:27:09 | $2.93 | 1,600 | $$5K | BUY |
| 14:30:02 | $2.96 | 1,189 | $$4K | SELL |
| 19:14:12 | $3.00 | 2,500 | $$8K | SELL |
5 dark pool trades shown · $$28K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Evaxion A/S (EVAX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →EVAX — frequently asked questions
What is EVAX stock price today?
Evaxion A/S (EVAX) is at $2.80, down 3.70% (-$0.11) at the Nov 12, 2026 close.
Why is EVAX stock moving today?
Latest EVAX news — Nov 10, 2026: Evaxion Updates SEC Filing Tied to European Investment Bank Debt Deal · Nov 9, 2026: Evaxion A/S amends SEC registration filing tied to European Investment Bank arrangement
What is the EVAX price target?
The average analyst price target for EVAX is $16.00, ranging from $16 to $16, based on 1 analysts.
What do analysts rate EVAX?
Analyst ratings for EVAX: 4 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did EVAX beat earnings?
EVAX last reported on Aug 20, 2026: EPS -$0.01 vs -$0.31 expected — a beat of 96.8%.
Does EVAX pay a dividend?
EVAX does not currently pay a dividend.
How much debt does EVAX have?
Evaxion A/S reported $8M of debt and $23M of cash (Dec 31, 2025).
What are EVAX support and resistance levels?
Support: $2.72, $2.26, $1.77. Resistance: $3.19, $3.64, $3.98.
What are insiders doing with EVAX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on EVAX?
Nov 10, 2026: Evaxion Updates SEC Filing Tied to European Investment Bank Debt Deal · Nov 9, 2026: Evaxion A/S amends SEC registration filing tied to European Investment Bank arrangement · Nov 8, 2026: Evaxion Releases Phase 2 Results for Cancer Vaccine EVX-01